Ultragenyx Pharmaceutical Inc. buy HC Wainwright
Start price
28.07.25
/
50%
€23.80
Target price
28.07.26
€68.10
Performance (%)
21.85%
Price
23.12.25
€29.20
Summary
This prediction is currently active. The prediction currently has a performance of 21.85%. This prediction currently runs until 28.07.26. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.286% | 4.286% |
| iShares Core DAX® | 0.650% | 3.212% |
| iShares Nasdaq 100 | 1.650% | 0.322% |
| iShares Nikkei 225® | 1.232% | 1.549% |
| iShares S&P 500 | 1.413% | 0.282% |
Comments by HC_Wainwright for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by HC_Wainwright for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€27.00
09.09.25
09.09.25
€67.95
09.09.26
09.09.26
7.41%
23.12.25
23.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.20
14.02.25
14.02.25
€90.54
14.02.26
14.02.26
-27.36%
23.12.25
23.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€42.00
24.12.24
24.12.24
€91.30
24.12.25
24.12.25
-30.95%
25.12.25
25.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€48.20
06.11.24
06.11.24
€88.68
06.11.25
06.11.25
-44.40%
07.11.25
07.11.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€38.80
01.08.23
01.08.23
€74.73
01.08.24
01.08.24
3.09%
02.08.24
02.08.24